MRNA | ||
---|---|---|
OUTLOOK RATING 1..100 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 2 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HQL | MRNA | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 1 day ago90% | 1 day ago75% |
Momentum ODDS (%) | 1 day ago82% | 1 day ago77% |
MACD ODDS (%) | 1 day ago85% | 1 day ago76% |
TrendWeek ODDS (%) | 1 day ago81% | 1 day ago79% |
TrendMonth ODDS (%) | 1 day ago80% | 1 day ago79% |
Advances ODDS (%) | 4 days ago81% | 4 days ago77% |
Declines ODDS (%) | 2 days ago86% | 2 days ago86% |
BollingerBands ODDS (%) | 1 day ago86% | N/A |
Aroon ODDS (%) | 1 day ago80% | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
COWZ | 54.50 | 0.59 | +1.09% |
Pacer US Cash Cows 100 ETF | |||
XHYH | 35.08 | N/A | N/A |
BondBloxx US High Yield Hlthcr Sctr ETF | |||
IDOG | 33.69 | -0.04 | -0.13% |
ALPS International Sector Div Dogs ETF | |||
IGEB | 44.47 | -0.19 | -0.43% |
iShares Investment Grade Systmtc Bd ETF | |||
NIM | 8.97 | -0.04 | -0.44% |
Nuveen Select Maturities Municipal Fund |
A.I.dvisor indicates that over the last year, HQL has been loosely correlated with MRNA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HQL jumps, then MRNA could also see price increases.
Ticker / NAME | Correlation To HQL | 1D Price Change % | ||
---|---|---|---|---|
HQL | 100% | +2.07% | ||
MRNA - HQL | 47% Loosely correlated | +5.13% | ||
GH - HQL | 36% Loosely correlated | -0.72% | ||
ILMN - HQL | 20% Poorly correlated | +0.50% | ||
ALNY - HQL | 19% Poorly correlated | -2.33% | ||
REGN - HQL | 10% Poorly correlated | +2.10% | ||
More |